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ABSTRACT

Title:
Structural and Regenerative Aspects of the Hydra Head Activator
Neuropeptide in the Newt, Notophthalmus viridescens
Name: Fuentes, Ernesto Jorge
University of Dayton, 1992
Advisor: Dr. P.A Tsonis
The hydra head activator (HHA) neuropeptide was first isolated from the
freshwater Cnidaria, Hydra vulgaris (formerly Hydra attenuata). Subsequent studies
have revealed its presence and conserved sequence (NH2-pGlu-P-P-G-G-S-K-V-I-L-FCOOH) in many species including mammals. In regenerating hydra, the peptide
influences head-specific differentiation of epithelial cells and acts as a mitogen. In
this study, the presence of the HHA peptide and its influence on regenerating newt
limbs (Notophthalmus viridescens) was investigated.

Immunohistological analysis

localized the HHA peptide in the adult newt brain, eye, intestine, and regenerating
blastema.
Nine-day limb regenerates were completely denervated by transecting the
brachial nerves. The following day, HHA-soaked beads were implanted into the
blastema under the wound epithelium and regeneration was studied for two weeks.
Results suggest a slight progression in blastema growth occurred compared to
denervated controls.
iii

The structure of the HHA neuropeptide has been previously studied using
NMR, CD, and Raman spectroscopy and determined to contain between 62-67%
anti-parallel ^-pleated sheet, and predicted to assume a /?-tum near the amino
terminus. We have utilized spectroscopic data with the Double-Iterated Kalman
Filter (DIKF) technique and CHARMm molecular mechanics to produce a molecular
model of the HHA peptide. Consistent with the secondary structure prediction, an
anti-parallel 0-pleated sheet topology was evident from the serine amino acid to the
carboxyl terminus. Additionally, a/J-tum occurred near the amino carboxyl terminus.
Results indicate that fluctuations occurring at both termini may serve to stabilize the
structure ultimately allowing the amino terminus access to its receptor protein.
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CHAPTER 1.
Review of Literature

1

The study of regenerative processes offers insight into the regulation and
maintenance of cellular growth and differentiation.

Since the pioneering

investigations of Trembley (1740), Spallanzani (1769) and numerous others,
regeneration of tissues and organs has been documented in many organisms such as
hydra, killfish, catfish, salamanders, and mammals (Goss, 1969).

In mammals,

regeneration is limited, while urodele (tailed) amphibians and the cnidarian hydra
have been studied extensively for their broad regenerative capabilities (Ord &
Stocken, 1984).
In 1769, Spallanzani was the first to report on the regenerative potential of
salamanders. In his account, Spallanzani describes the phenomena of tail and limb
regeneration in several species (Spallanzani, 1769). Today, the urodele amphibians
such as the newt (Notopthalmus viridescens) and the axolotl (Ambystoma mexicanum),
the only vertebrates that are able to undergo regeneration as adults, have become
model systems for the study of regeneration phenomenon and limb pattern formation.
An urodele amphibian can regenerate an experimentally amputated limb at
any level on the proximal-to-distal axis (shoulder to fingertip) beginning at the plane
of amputation (reviewed by Stocum, 1984). Upon amputation of the limb, wound
healing begins by the migration of epidermal cells to the amputation plane, forming
the wound epidermis. These epidermal cells accumulate at the wound site yielding
a thickened apical epidermal cap. Mesodermal cells, such as cartilage and muscle,
beneath the epidermal cap dedifferentiate to unspecific, embryonic-like cells resulting
in an apical bud termed blastema.

The blastema enlarges due to cellular
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proliferation, redifferentiates, and undergoes pattern specification. The final stages
of limb regeneration involve morphogenesis whereby the limb stump extends distally
with concomitant formation of any missing digits (Goss, 1969; Stocum, 1984; Tsonis,
1991).

Detailed morphological accounts and specific staging systems for limb

regeneration have been published elsewhere and will not be discussed here (Iten and
Bryant, 1973; Tank et al., 1976; Washabaugh and Tsonis, 1991).
The limb regeneration process is inextricably dependent upon the formation
of an epithelial wound covering, adequate innervation (presence of nerves), blastema
cells, and appropriate chemical "factors" (Liversage 1987; Tsonis 1991). The apical
epithelial covering provides protection, positional cues and patterning information.
The importance of the wound epithelium is underscored by the failure of limbs to
regenerate when the epidermal cap is UV-irradiated or completely removed
(reviewed by Stocum, 1985).
An adequately innervated limb will regenerate normally while denervation
prevents or delays the formation of a limb regenerate (reviewed by Singer, 1952).
Singer’s "nerve threshold" theory postulates that nerves provide a trophic or
neurotrophic influence on the blastema only when sufficient innervation is present
Therefore, below some particular threshold of nerves, neurotrophic activity ceases
and regeneration is inhibited. Specifically, denervation has been reported to affect
the blastema cell cycle at the Gj (Maden, 1978 and 1979) and G2 stages (Tassava,
1978). Moreover, denervated limbs have reduced DNA and protein synthesis which
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can be partially rescued by the infusion of nerve extracts (Lebowitz and Singer, 1970;
Jabaily and Singer, 1977).
The local chemical environment surrounding the regenrating limb seems to be
crucial. Liversage (1985) proposes the "hormonal milieu" concept which implies that
a sufficient and specific quantity of hormonal background is necessary for
regeneration to proceed. This point is emphasized by the inhibition of regeneration
upon hypophysectomy (Liversage and Globus, 1977; Liversage et a t, 1985).
The process of limb regeneration is one of specific cellular responses to
trophic, mitogenic, and morphogenic factors (Brockes, 1984; Liversage, 1987). These
factors act at the cellular level and control specific aspects of cell differentiation and
proliferation. These factors include retinoids, growth factors, and peptide hormones.

Retinoids
The retinoids are a class of compound containing a hydrocarbon ring and an
attached conjugated hydrocarbon chain whose terminus is polar. These compounds
are synthesized in animals from plant carotenoids. A representative member of these
compounds is Vitamin A (retinol) which is synthesized and stored in the liver and
released to tissues via the circulatory system.

Once in the tissues, retinol is

carboxylated and the resulting product termed retinoic acid (Blomhoff et al., 1990).
Retinoic acid (RA) seems to have two major functions. RA appears to be
involved in epithelial cell differentiation and is intimately involved in the positional
memory of regenerating and developing cells (reviewed by Brockes, 1989).
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In

regenerating urodele limbs, the blastema is "proximalized" due to RA. The positional
memory of the cells is altered and the blastema behaves as though it were derived
from a more proximal location (Thomas & Stocum, 1984; Maden, 1982). These
effects are dose and time-dependent and most pronounced when administered early
in blastema formation (Maden et al., 1985).
The urodele limb with RA has become an widely used experimental system
for limb developmental and regeneration studies.

The action of RA has been

proposed to be mediated via a receptor-ligand complex analogous to steroid-hormone
complexes. In the current model, the hormone binds to the monomeric receptor
inducing translocation to the nucleus and/or receptor dimerization. The dimer then
binds to its target DNA response element which influences transcriptional events
(Beato, 1989; Evans, 1988).

Recently, a gene was isolated (RA Ra) that shares

homology with the steroid hormone receptor superfamily and codes for a protein that
binds retinoic acid (Giguere et al., 1987; Petkovich et al., 1987). Giguere et al. (1989)
have investigated the spatial expression of the RA R a gene in blastema tissue and
found no significant differences along the proximal-to-distal axis as one might expect
for a morphogen that alters positional memory. To date several other retinoic acid
receptors have been isolated leading to the designations of RARa, RAR/J, RARy,
and RXRa (Blomhoff, 1990). Evidence now suggests that these receptors may form
dimers among themselves and/or with other steroid receptors (thyroid hormone and
vitamin D3 receptors) adding an additional level of complexity to their mode of action
(Bugge et al., 1992). In addition to the nuclear RAR, cytoplasmic retinoic and retinol
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binding proteins (CRABP and CRBP) have been isolated (Blomhoff, 1990). Thenfunction is elusive, however, there is speculation that they may act to sequester RA
and retinol for later use by the cell.

Growth factors
Several growth factors have been associated with neurotrophic and mitogenic
events. Most noteworthy are the fibroblast (Carlone and Mescher, 1985) and glilial
(Brockes & Kintner, 1986) growth factors. The fibroblast growth factor (FGF) has
been isolated from the brain and pituitary by several laboratories (Gospodarowicz,
1974; Westall et aL, 1978). In each case that mitogenic activity was found, however,
there remain discrepancies between the chemical characterization of each isolate.
The mitogenic activity of FGF was initially found in fibroblasts and since then a
proliferative effect has been noticed on newt regenerating blastema (Mescher & Loh,
1981).
The glial growth factor (GGF), a true neuromitogen, was first identified by its
mitotic activity on rat Schwann cells - cells which notoriously lack response to
mitogens (Raff et aL, 1978). The GGF is a basic protein with an apparent molecular
weight of 31,000 daltons.

In urodele amphibians it is present in nervous and

blastemal tissue but upon denervation is no longer detectable (Brockes & Kintner,
1986).

Furthermore, GGF was responsible for the induction of mitosis as seen

through an increased thymidine labelling index.
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Peptides

Although most studies concerning mitotic factors have centered on proteins,
recent studies have shown that neuropeptides and peptide hormones may also possess
mitotic activity (Globus & Alles, 1990). Bombesin was first isolated from frog skin
and is known to elicit the release of a host of other peptides including insulin and
prolactin (Rozengurt & Sinnett-Smith, 1983). Rozengurt and Sinnett-Smith were able
to show that bombesin is a potent mitogen on 3T3 cells and works synergistically with
insulin. Recently, Globus and Alles (1990) have purportedly detected members of
the tachykinin family (eledoisin, kassinin, substance K and neuromedin K) and the
non-tachykinin bombesin and met-enkelphalin in newt brain and spinal cord, however
their localization in the blastema was not well defined.
In the same study, substance P (SP) was successfully localized and
characterized in the blastema. It was predominately distributed along the periphery
of epidermal cells while the basal germinative epidermal layer remained unreactive.
In further experiments, the intensity of SP antisera reaction was found to correlate
with the expected density of innervation in the epidermis. Previously, it was shown
that SP behaves as a mitogen in cultured blastema cells and its action could be
suppressed by the inclusion of anti-SP in the culture (Globus et al., 1983). Together,
this data suggests a possible link between the localization of SP and its mitogenic
effect on the blastula. Possibly, its role is to act on epidermal cells which in turn
release factors which are responsible for the observed mitotic effect. Triparte control
of limb regeneration was proposed by Globus (1978). In this model, nerves, the
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apical epidermal cap, and insulin are essential for limb regeneration. Subsequent
studies revealed insulin to be a potent promoter of cultured blastema cells
(Vethamany-Globus, 1987).

From in vivo experiments, somatostatin, a known

inhibitor of insulin release, was suggested to be responsible for the inhibition of limb
regeneration (Vethamany-Globus, 1987).
The hydra head activator (HHA) neuropeptide, as the name implies, was first
recognized in the freshwater Cnidaria, Hydra attenuata. Subsequent studies have
revealed its conserved presence through many species including mammals
(Bodenmiiller and Schaller, 1981).

In hydra, the head activator neuropeptide

functions as a growth and differentiation factor. In a dose dependent fashion, the
neuropeptide is mitogenic to all cell types arrested at the G2 transition.

As a

differentiation factor, the HHA neuropeptide targets epithelial and interstitial stem
cells. These cells, once stimulated by the HHA neuropeptide will differentiate to
head- specific ectodermal, endodermal, or neural cells.
In addition to HHA’s conserved sequence, there is evidence that the growthcontrolling function of the peptide may also be preserved. The H H A has been
isolated from the human hypothalamus and brain tissues of several other mammalian
species (Bodenmiiller & Schaller, 1981). In developing rat embryos, the expression
of HHA appears early and lasts throughout development (Schaller et aL, 1989a).
Furthermore, HH A is also present in tumors and tumor cell lines of neural and
endocrine origin (Schaller, 1985). One particular study suggests that the HHA
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peptide acts as an autocrine growth factor at the G^mitosis transition of a
neuroblastoma cell line (Schaller et al., 1989b).
Interestingly, the activity of the HHA in other commonly used regenerative
model organisms has not been reported in the literature. In amphibian urodeles, it
seems to be a logical candidate as a neuromitogen - it originates in neural tissue and
possesses mitogenic activity.
The essential role of nerve cells seems to be linked to the several growth and
stimulatory factors they produce and subsequently release. Other chemical factors
such as peptide hormones and retinoids also seem to play a crucial role in
regeneration. These factors have been implicated in the induction of mitosis and
morphogenesis and hence are considered mitogenic and morphogenic factors.
Additionally, the formation of chemical gradients for differential expression of these
factors may be the final influencing determinant for the sustained progression of
development and regeneration.
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CHAPTER 2.

Expression of Hydra Head Activator in Newt Tissues and
Effects on Limb Regeneration
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Abstract

In this study, the presence of the hydra head activator (HHA) neuropeptide
and its influence on regenerating newt limbs (Notophthalmus viridescens) was
investigated. Immunohistological analysis has localized the HH A neuropeptide in the
adult newt brain, eye, intestine, and regenerating blastema. Experiments in which 9
day limb regenerates were denervated and subsequently implanted with HHA-soaked
beads suggest a slight progression of blastema growth compared to denervated
controls.

15

Introduction

The adult newt, Notophthalmus viridescens, is widely known for its ability to
regenerate an injured or surgically amputated limb. Initially, epidermal cells migrate
from the periphery of the wound producing an apical epidermal layer. This wound
epithelium is crucial to the regenerative process; in its absence, limb regeneration
does not proceed. As limb regeneration continues, differentiated cells such as muscle
and cartilage dedifferentiate into embryonic-like mesenchymal cells. These cells,
known as blastema cells, proliferate and begin to accumulate beneath the wound
epithelium. Eventually, the blastema cells re-differentiate into the new cartilage and
bone cells of the regenerating limb. Finally, morphogenesis will ensue replacing any
missing structures of the amputated limb (Goss, 1969; Tsonis,1991).
The nerve-dependence in newt limb regeneration has been well documented
(Singer, 1952). It has been shown that adequate innervation is necessary for proper
limb regeneration and that a completely denervated limb will not regenerate.
However, this nerve- dependence of the limb blastema is required only during the
first 17 days post-amputation. Once a nerve-dependent blastema has been deprived
of its nerve supply, it ceases to grow and is subsequently resorbed. In contrast, a
nerve-independent blastema (blastema older than » 17 days) is able to re
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differentiate and morphogenesis can lead to a regenerated limb (Singer and Craven,
1948).
On the molecular level, denervation of the limb blastema results in the
reduction of protein, RNA, and DNA synthesis. Tassava and colleagues have shown
that in the absence of nerves, dedifferentiation of stump cells does occur along with
DNA synthesis, but cell division is arrested (Tassava, 1978; Mescher, 1982).

In

contrast, Maden (1978) has proposed that nerve fibers influence either the total
number of blastema cells cycling or the rate at which they cycle by varying the length
of the Gi phase. Tassava et al. (1987) suggest that the blastema cell cycle is a
"punctuated" phenomena whereby cells are constantly alternating between active
cycling and transient quiescence. In any case, it seems that adequate innervation may
provide cues which allow arrested cells to continue cycling and hence advance the
proliferation of the blastema.
The reliance of the early blastema upon adequate innervation has been
described by Singer (1952) as a neurotrophic phenomenon.

This neurotrophic

phenomena is hypothesized to originate in nerve fibers and postulated to promote
blastema cell proliferation.

Although the identity of this neurotrophic "factor(s)"

remains unknown, several candidate molecules have been investigated (Carlone and
Mescher, 1985; Brockes, 1984).

Furthermore, several lines of evidence strongly

suggest the neurotrophic "factor" is a protein or peptide molecule (Singer et al.,
1976).

Separate studies have implicated divalent calcium (Foret, 1973), cyclic

nucleotides (cAMP and cGMP) (Globus et al., 1987), and inositol phosphates (Tsonis,
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1991) as mediators of this neurotrophic effect. Recently, Globus and Alles (1990)
investigated the presence of several neuropeptides such as substance P, neurotensin,
and bombesin in the regenerating limb blastema, however their specific roles in
regeneration were not detailed.
In hydra, a neuropeptide is responsible for head-specific growth and
differentiation of epithelial and interstitial cells (Schaller et al., 1989a).

This

neuropeptide, the hydra head activator (HHA) was first isolated from the freshwater
Cnidaria, Hydra vulgaris (formerlyHydra attenuata) (Schaller and Bodenmuller, 1981).
Subsequent studies have revealed its presence and conserved amino acid sequence
(pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe) in many species including mammals
(Bodenmuller and Schaller, 1981).
In addition to HHA’s conserved sequence, there is evidence that its growth
controlling function may also be preserved.

In developing rat embryos, the

expression of HHA appears early in the brain and intestine, lasting throughout
development (Schaller et al., 1977). The HHA has been found in tumors and tumor
cell lines of neural and endocrine origin (Schaller et ah, 1988). In neuroblastoma cell
lines, cellular growth is dependent upon the neuropeptide where it acts as an
autocrine growth factor at the G^mitosis transition (Schaller et al., 1989b). Kajiwara
and Sato (1986) have shown that the HH A stimulates DNA, R N A and protein
synthesis in cultured chick embryo brain cells. This study also provides evidence that
HHA induces an increase in cellular cAMP with concomitant decrease in cGMP. We
have raised the possibility that the HHA may have an influential role in the
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regenerating newt limb. In this study, the presence of the HHA neuropeptide and
its ability to promote blastema proliferation was investigated.

Materials and Methods

Animals and surgical techniques

Adult newts, Notophthalmus viridescens, were obtained from Charles Sullivan
Co., Nashville, Tennessee were maintained in treated tap water at 21-25°C and fed
raw chicken or beef liver two or three times weekly. Prior to all surgical procedures,
animals were anesthetized with 0.01% phosphate-buffered aminobenzoic acid ethyl
ether at pH 7 (Sigma Chemical Co.). Forelimb amputations were bilateral at the
mid-radius/ulna level. Left forelimbs were denervated using fine forceps by severing
the brachial nerves distal to the brachial plexus (Goldhamer and Tassava, 1987). The
success of denervation was demonstrated by lack of limb movement and lack of
response to sensory stimulation. Bead implantations were performed on ten-day limb
regenerates using a fine, glass microinjection needle. In each case, approximately 4-5
beads were implanted into the blastema through the wound epidermis. Control limbs
were punctured and received no implant beads. Previous studies have determined
that beads alone have no effect on the limb regenerate (our previous studies, Wanek
et al., 1991).
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Immunohistochemistry

Adult newts were amputated as previously stated. At one or two weeks post
amputation, limbs and tissue specimens were excised and immediately frozen in
O.C.T. compound (Miles, Elkhart, IN). Cryostat sections were cut longitudinally
between 6 and §um along the anterior-posterior axis and placed on precleaned slides.
The primary antibody to the HHA neuropeptide (code K-8303) was raised in
rabbit (Ekman et al., 1990) and diluted 1:50 with phosphate-buffered saline (PBS).
Prior to staining, all sections were rehydrated using PBS containing 5% goat serum
albumin. Primary staining was visualized using a 1:20 dilution of IgG fluorescein
isothiocyanate (FITC)-conjugated goat anti-rabbit antiserum (Sigma Chemical Co.).

Preparation o f bead implants

HHA neuropeptide

(Sigma Chemical Co.) was monomerized at a

concentration of 0.45mM using 3M ammonium sulfate as previously described
(Bodenmuller et al., 1986). This stock solution was subsequently diluted to 13.4/xM
(0.017mg m l1) with 1% BSA and 0.1M NaCl and used to completely saturate AG1X4 basic anion exchange resin beads (Bio-Rad, 105-250 /4m diameter) overnight at
4°C. These beads have been used in previous studies to slowly deliver hydrophobic
retinoid molecules locally (Wanek et al., 1991). Assuming 100% adsorption by the
beads, the maximum amount of peptide per bead would be approximately 3 /4g.
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Histological analysis

At appropriate times, experimental and control limbs were removed, fixed
using Bouin’s fixative and decalcified with 10% trichloroacetic acid. Treated limbs
were imbedded in paraffin and sectioned longitudinally at 8-lQum. Sections from
each limb were taken through a graded ethanol series and processed using Gomori’s
trichrome stain and hematoxylin. Brightfield microscopy was used for tissue section
analysis.

Results and Discussion

Immunolocalization
The presence of the HHA neuropeptide in several species including mammals
has been documented (Bodenmiiller et al., 1981; ScMwller et al., 1977). In these
studies, the peptide was either chemically extracted or detected by immunological
assay in rat and human tissues. Specifically, significant amounts were found among
the following tissues:

intestine, eye and brain. Blood serum also contained the

neuropeptide, and it was found at elevated levels in individuals with brain tumors
(Schaller et al., 1988). Our results indicate the expression of the neuropeptide in
adult newt tissues. Using polyclonal antisera and indirect fluorescence detection, the
HH A immunoreactivity was evident in newt intestine, eye, limb blastema (Fig. 1), and
brain (data not shown). Intestinal tissue demonstrated a high degree of fluorescence
when exposed to HHA antisera (Fig lb). Staining was cytoplasmic and most intense
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on the lumenal epithelial layer. This tissues demonstrated the highest amount of
immunoreactivity. The newt eye also displayed HH A immunoreactivity (Fig. lc).
Fluorescence patterns in the eye was strong for the outer corneal epithelial layer;
only slight staining was evident for the interior corneal cells.
In addition to the above tissues, regenerating limbs (17 days post-amputation)
were examined by immunofluorescence. Figure la shows distinct fluorescence in the
apical epidermal layer of the limb regenerate. The intensity of staining was greatest
on peripheral epidermal layers and diminished near the basal germative layer.
Immunoreactivity was also evident in the mesenchymal cells, but at a lower level than
found in the epidermis. These results are in agreement with previous studies of
other, unrelated neuropeptides.

Globus and Alles (1990) investigated several

tachykinin (substance P, eledoisin, kassinin, substance K and neuromedin K) and non
tachykinin (bombesin, nerotensin, and net-enkephalin) neuropeptides.

Of these,

substance P yielded the strongest immunoreactivity displaying a similar staining
pattern to that found with the HHA neuropeptide. An identical staining pattern was
obtaiMwd for limb regenerates which were denervated as in Materials and Methods
(data not shown). This result suggests the origin of the HH A is the limb itself,
possibly the wound epithelium.

Limbs treated with exogenous HHA neuropeptide

Twenty-one adult newts were amputated bilaterally and allowed to regenerate
nine days, at which time left forelimbs were denervated.
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On day ten, eleven

denervated limb regenerates were implanted with HHA-soaked beads.

The

innervated right limbs of each animal served as control for normal regeneration. The
remaining ten animals were used as negative controls, representing denervation alone.
In general, denervated control limbs became arrested and did not progress
further (Fig. 2b). Similar results have been reported extensively in the literature
(Singer, 1952). No re-differentiation was evident and the density of blastema cells
were noticeably reduced when compared to normal regenerates (Fig. 2a).
Experimental limbs containing HHA-soaked beads, demonstrated a slight
accumulation of blastema cells in 2/11 cases. As depicted in Fig. 2c, one can see an
apparent increase in blastema cells in treated limb stumps, though not an
accumulation as in normal regenerates. It could be that the HHA has a limited
effect, but it does not seem to be sufficient as a neurotrophic factor. The presence
of the HHA in the wound epithelium could argue for a signalling function in the
regenerating limb, possibly via cyclic nucleotides. Further studies on the function(s)
of the HHA and its receptor molecule could elucidate the specific functions of the
neuropeptide on regenerative tissues other than hydra.

23

Figure 1. Hydra head activator immunoreactivity in newt tissues. (A) Normal 17-day
newt regenerating limb blastema (we, wound epithelia; b, blastema cells), 75 X. (B)
Newt intestinal tissue (1, lumen), 150 X (C) Eye tissue (comeal epithelia), 150 X
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Figure 2. Effect of exogenous administration of the hydra head activator on
regenerating newt limb blastema. In all figures, the dashed line represents the plane
of amputation. The radius (r) and ulna (u) are depicted. Mesenchymal blastema
cells (b) are labelled. Photographs were taken at 75 X. (A) A four-week normal,
innervated regenerate displaying a full blastema and thick epidermal cap. (B) A fourweek blastema which was denervated nine days after amputation. This blastema
shows few mesenchymal cells and a thin epidermal cap. (C) This blastema was
amputated and denervated as in (B). However, exogenous HH A was delivered
locally (arrow) to the regenerate via a HHA-soaked bead. This regenerate displays
a slight progression of blastema cells over (B), however it does not reach the size of
normal regenerates (A).
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CHAPTER 3.

On the Three-dimensional Structure o f the Hydra Head Activator Neuropeptide
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Abstract

The structure of the Hydra head activator (HHA) neuropeptide has been
previously studied using NMR, CD, and Raman spectroscopy and determined to
contain between 62-67% anti-parallel ^-pleated sheet, and predicted to assume a
tum near the amino terminus. We have utilized spectroscopic data with the DoubleIterated Kalman Filter (DIKF) technique and CHARMm molecular mechanics to
produce a molecular model of the HHA neuropeptide.

Consistent with the

secondary structure prediction, an anti-parallel ^-pleated sheet topology was evident
from the serine amino acid to the carboxyl terminus. Additionally, a /J-tum occurred
near the amino carboxyl terminus. Results indicate that fluctuations occurring at both
termini may serve to stabilize the structure ultimately allowing the amino terminus
access to its receptor protein.
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Introduction

The Hydra head activator (HHA) neuropeptide was first isolated from the
freshwater Hydra attenuta (Schaller and Bodenmiiller, 1981).

In hydra, this

neuropeptide is required for the growth and differentiation of the head region
(Schaller et al., 1990). Subsequent studies have revealed HHA’s presence, with
conserved amino acid sequence, in several species including mammals (Bodenmiiller
and Schaller, 1981). More recently, the HHA has been chemically extracted from
mammalian tissues including rat and human brain, intestine, and blood serum
(Schaller et al., 1977; Schaller et al., 1988). Additionally, tumor cell lines and patients
having brain tumors have been shown to possess an abundance of the HHA, as have
developing rat and human embryos (Schaller et al., 1989; Schaller et al., 1988).
These findings suggest a role for the HHA in growth and development in mammals.
The primary sequence of the HHA neuropeptide has been determined as
pGlu1-Pro2-Pro3-Gly4-Gly5-Ser6-Lys7-Val8-Ile9-Leu10-Phe11, the amino terminus being
pyroglutamic acid. This sequence displays little homology to other general sequences,
although the bradykinins share a limited homology near the amino terminus
(Xxx-Pro-Pro-Gly-Xxx-Ser). Interestingly, both peptides are able to stimulate ileum
and uterus contraction (Schaller and Bodenmuller, 1981; Bodenmuller and Roberge,
1985). Immunological and biochemical studies have shown that the neuropeptide’s
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action is receptor mediated and biologically inactivated by self-aggregation (Schaller
et al., 1988; Bodenmiiller et al.,1986). Two receptors have been identified in the
hydra which apparently mediate HHA’s biological activity, possibly via cyclic
nucleotides (Neubauer et al., 1991; Kajiwara and Sato, 1986). Knowledge of the
HHA-receptor interactions is limited. However, amino acid mutation studies as well
as immunological assays demonstrate a crucial role by amino-terminal residues for
receptor binding and biological activity. In fact, cleavage of the pGlu1 ring or its
substitution by Tyr-Gln have resulted in biologically inactive peptides. Interestingly,
alterations at the carboxyl terminal have also been effective in eliminating function
(Birr et al., 1981).
Spectroscopic analysis and secondary structure prediction algorithms suggest a
^-pleated conformation and a /3-tura near the center of the neuropeptide.
Specifically, experimental data from CD and Raman spectroscopy estimate between
62-67% /3-pleated sheet in the anti-configuration (Bodenmiiller et al.,1986). One and
two-dimensional 2H-NMR experiments have been performed and are consistent with
this secondary structure data (Saffrich et al., 1989). No structural heterogeneity in
the solution structure was evident, implying only one dominant conformation within
the NMR time-scale. Assigned NOEs indicate a trans-configuration for the peptide
bonds between residues pGlu1, Pro2, and Pro3.

Moreover, cleavage of the

pyroglutamic ring did not induce any unexpected spectral modifications suggesting no
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global conformational changes.

Together, this spectroscopic data has provided

secondary structure information, although no detailed three-dimensional model has
been reported. It is the purpose of the present study to predict a general topology
for the hydra head activator neuropeptide.
A few strategies have been developed to enable the incorporation of
experimental data, e.g. distance constraints derived from NOEs, to Cartesian
coordinate space in order to obtain a three-dimensional topology (Crippen, 1977;
Havel et ah, 1983).

Recently, the PROTEAN methodology was introduced for

protein solution structure determination. This method uses principles of Bayesian
probability, namely the double-iterated Kalman filter procedure (DIKF), to
sequentially refine estimates of the mean position and the variance of each atom.
Thus a set of atomic positions consistent with the applied constraints, as well as an
explicit quantification of the uncertainty in atomic position for each segment of the
protein is provided (Altman and Jardetzky, 1989; Altman et al., 1989; Pachter et al.,
1990). The technique was shown to perform well for deriving a structure from NMR
data of the cyclic peptide Cyclosporin A (Pachter et ah, 1992), the lac repressor
headpiece (Altman et al., 1989), both the secondary structure (Arrowsmith et al.,
1990) and tertiary structure of the trp repressor (Arrowsmith et al., 1991), and of the
Kunitz inhibitor domain of the amyloid precursor protein involved in Alzheimer’s
disease (Batchelder, in prep.). In this study, we have used secondary structure data
with the DIKF and CHARMm molecular dynamics modeling techniques to develop
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and analyze a detailed three-dimensional fold of the hydra head activator
neuropeptide.

Materials and Methods

Theory o f double iterated Kalman filter

The structural model is described by the state vector x which consists of a list
of the mean positions (x, y, z cartesian coordinates) for each of the atoms in the
protein. The elements of the general error covariance matrix C(x) for any two atoms
M, N are symmetric sub-matrices:
T
C(MN) =
L

xMyN

G xMzN

G yMxN

& yMyN

G yMzN

& zMxN

O zMyN

G zMzN

& xMxN

1
J

The variance-covariance matrices on the diagonal of the covariance matrix [C(MM)]
describe the extent of three-dimensional uncertainty in the position of the atom M.
The sequence of distance or dihedral angle measurements z are represented by the
appropriate non-linear function of the state vector h(x) and an assumed additive
variance v. Stereochemical constraints such as the co-planarity of peptide bonds,
aromatic rings and chirality are introduced by using suitable dihedral angles, or
alternatively, the appropriately derived distances. Distance constraints also include
covalent bond lengths, distances implied by bond angles, NOE distance constraints
and any non-standard connectivities, for example, hydrogen bonds.

Given this

information, a sequential linear estimator for the minimum variance estimate of the
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state can be obtained by utilizing the extended Kalman filter in the non-linear case
(Gelb, 1984), originally introduced by Kalman (1960). This scheme is a conditional
probability based (Bayesian) sequential estimation method, in which the experimental
constraints z are compared with the corresponding values predicted from the
estimated geometry of a given structure x and its variance-covariance C(x), as well
as from the measurement model h(x) and the variance v :
x(+ ) = x(-) + K {z - h(x(-))}
C (+ ) = C(-) - K H C(-)
K = C(-) EF {H C(-) HT + v } 1

[1]

where (-) signifies a previous (-) structural representation, which is sequentially
updated (+). The rigorous criterion for the choice of the Kalman estimator gain
matrix K is to minimize a weighted scalar sum of the diagonal elements of the error
covariance matrix C. Moreover, there is an intuitive logic behind the equation for
the magnitude of the adjustment K, namely, it can be seen as the "ratio" between the
uncertainty in the estimate and that of the measurement. Particularly, if the variance
of the experimental measurement is small relative to the variance of the predicted
measurement as calculated from the current structural model, then the structure is
updated to bring it into agreement with the experimental data. On the other hand,
if the variance of the experimental measurement is large relative to the variance of
the predicted measurement, then the structural model is updated only slightly to
reflect the greater confidence in the structure than in the uncertain data information.
The term within the inverse describes {C(z) = C(h(x)) + v} for the particular
condition of a non-linear measurement model, since in the case of non-linearity,
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C(h(x)) corresponds to the first-order Taylor approximation of h(x), where H is the
derivative of the data model, and H its transpose.
The extended Kalman filter approach can be used to obtain higher-order
non-linear filters, and we adopted an iterative procedure for this purpose (Denham
and Pines, 1966). The iterated extended Kalman filter for an iteration k is obtained
by re-writing Eq. [1] :
< + ) ,= x(-) + K, {z - [ « < + ) ,.,) + H(x(-) - x(+),.,)]>

[2]

with similar expressions obtained for C (+ )kand the appropriate K,.. This iterative
procedure is carried out for each one of the constraints. However, since the filter is
not optimal in the non-linear case, residual inaccuracies could still result. Thus, the
final mean positions are used for another cycle (1) of updating. The covariance
matrix is re-set to its initial large value in order to allow the atoms freedom to move
in response to the constraints, and all measurements are re-introduced into the
system for each of these doubly iterated cycles. These successive cycles are repeated
until all constraints are satisfied to within a pre-set threshold of standard deviations.
The DI KF method is coded in the PROTEAN - Part II and was utilized in all
computations (Altman et al., 1990). The algorithm updates the structural model
(equation [2]) for a maximum of three iterations (k) for each of the distance
constraints, with a threshold of 0.1 standard deviations for termination of the iterative
procedure, while the number of cycles (1) for reaching convergence varies according
to the experiment performed. In addition, at the end of each cycle all of the distance
constraints are sorted according to the corresponding error evaluated from the
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updated structure, so that the constraints with the worst errors are applied first in the
next cycle.

Modeling o f hydra head activator

The hydra head activator neuropeptide primary sequence was built using
programs contained within PROTEAN - Part II.

This sequence had a glutamine

replacing the non-standard pyroglutamic residue.

The input for the algorithm

consisted of distance and angle constraints in the form of mean values along with
associated variances.

Specifically, distance variances were 0.1 A2 while angle

variances remained at 25“2 The amino terminal Gin1, Pro2 and Pro3 0 2,

an^ V>2

angles were positioned at -55 “, -60“, and +145 “, respectively (Cantor and Schimmel,
1980). Furthermore, ten omega angles (C„-C„) were set at 180“ of to retain a trans
configuration across the peptide bond.

Based on spectroscopic data, <p and ip

backbone angles for Ser6, Lys7, Val8, He9 and 0 of Leu10were placed at average values
for anti-parallel ^-pleated sheet (0 = -139 “, ip = +135 “) (Cantor and Schimmel, 1980).
The aromatic ring of Phe11 was kept planar.

Finally, 200 bond distances were

assigned based on typical chemical bonding distances.

In total, 228 angle and

distance constraints were used as input to the structure determination computer
algorithms coded in PROTEAN - Part II.

This methodology allows a mean

three-dimensional structure, consistent with experimental data, along with a variance
and covariance of all atomic positions to be calculated.
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Further refinement of the three-dimensional structure was carried out by
performing molecular mechanics and dynamics calculations. Prior to modeling, all
atom and bond types were verified and the amino-terminal glutamine was converted
to pyroglutamic acid. The modeling protocol involved an initial energy minimization
using the CHARMm force field energy function (Brooks et al., 1983) and subsequent
integration of the classical Newtonian equation of motion to determine the position
of atoms at later time points. The CHARMm force field energy function contained
all default terms, excluding hydrogen bonding. In addition, a dielectric constant of
unity and a time step of 5 femtoseconds was used for the dynamics simulations.
Routinely, 10,000 steps of Steepest Descent (SD) energy minimization followed by
Conjugate Gradient (CG) minimization were employed prior to molecular dynamics
simulations. The neuropeptide was initially heated to 300 °K over a 5 ps span.
Equilibration and simulation periods were performed at 300 ’K for 5 ps and 50 ps,
respectively. Over the 50 ps dynamics simulation, 1000 structures were written out
for analysis.

All computations were performed on a Cray X-MP and a Silicon

Graphics Workstation.

Results

A three-dimensional fold for the hydra head activator neuropeptide was
determined using experimental data derived from circular dichroism (CD) and
nuclear magnetic resonance (NMR) in conjunction with theoretical techniques. After
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being subjected to 40 cycles of the extended double iterated Kalman filter algorithm
(DIKF), the average variance of the initial structure converged to less than 0.1
standard deviations (Figure 1). The mean position of the final structure from the
DIKF calculation was subsequently used as a starting point for further refinement
with molecular mechanics and dynamics.
The overall topology of the hydra head activator peptide is quite consistent
with experimental data. Evident from the average dynamics structure (Figure 2 and
Table I), the neuropeptide contains a /?-turn near the mid-region. This bend allows
for spatial proximity and bonding interactions between the amino and carboxyl
termini. As seen in Table I, residues near the carboxyl terminus have <j>and ip torsion
angles within the range for anti-parallel ^-pleated sheet conformation, 0 *» -139° and
tp~ +135 ° (Cantor and Schimmel, 1980), while the amino terminus is less well defined.
The flexibility of the molecule is readily apparent by examining sequential
coordinate frames of the dynamics simulation.

However, a more quantitative

measurement of flexibility can be seen in Figure 3, where the range of values for each
0 and 0 torsion angle are plotted throughout the dynamics simulation. This plot
emphasizes residues that demonstrate large fluctuations during the dynamics
calculation. Transitions of 100° in the backbone angles are typical, though several
residues show larger deviations. In particular, Pro3, Gly4, Gly5, Ser6 and Leu10 all
display fluctuations near or over 200°. These residues represent regions of the
neuropeptide having the most flexibility.
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It is interesting to examine particular torsions as a function of elapsed time
during the dynamics simulation. In Figure 4, such plots are given for pGlu1, Pro3, and
Leu10. For comparison, Figure 4b depicts the trace of 0 3 over time and shows typical
oscillations around an average torsion of -74°. Furthermore, no unique or repeating
transitions are present suggesting little impact upon the overall structure. In contrast,
traces of

and ipw (Figure 4a, 4c and 4d, respectively) exhibit larger fluctuations

in torsion values.

The variation in

V’i

and ipw is expected due to the inherent

movement in unrestrained terminal residues. Their significance is underscored by
mutational studies which indicate specific contacts between these residues are
necessary for receptor binding and subsequent biological function (Birr et al., 1981;
Schaller et al., 1989).

Characteristic and repeating transitions are evident in ifo

(Figure 4c). These distinct transitions can be characterized by two specific structural
features as seen in Figure 5. When ip3 is above +140°, a highly stabilized structure
containing a/J-tum is apparent (Figure 5a, 5b, and 5d). This model predicts extensive
hydrogen bonding between residues comprising the /3-tum. Indeed, residues Pro3,
Gly4, Gly5 and Ser6 show hydrogen bonding (Table II). Figure 5c and 5e, represent
a structure where hydrogen bonding between the amino and carboxyl termini occurs
periodically. This structure is characterized by interactions between pGlu1 and Val8,
He9, Leu10 and Phe11 (Table II).
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Discussion

The determination of the three-dimensional structure of small peptides poses
a special challenge to the researcher largely due to the inherent flexibility of peptide
molecules (Dyson and Wright, 1991). In lieu of crystallographic data or sufficient
NMR interatomic distances, this challenge can be prohibitive. Thus, theoretical
approaches such as molecular dynamics and other algorithms have become important
for elucidation of structural and energetic aspects of peptides (Hagler et. ah, 1985;
Altman, 1990). Here, we have employed a methodology which incorporates readily
available secondary structure data and a limited set of tertiary structural information
into a molecular model.
In general, this strategy is computationally efficient and accurate as long as
each stage in the course offers the next one a rigorous upper bound (Altman et al.,
1989). This approach meets the major objections of Metzler et al. (1989) and Levy
et al. (1989) to structure determination by distance geometry, since no structure is
excluded from the system unless it does not satisfy the constraints. The estimates of
mean and variance are updated using conservative constraint estimates one at a time,
and there is no global optimization criteria which allows "error tradeoff' (a low
average error at the expense of a few individually large errors). The resulting initial
fold we calculated is therefore in good agreement with the experimental data.
The refined three-dimensional structure indicates that the neuropeptide
contains a/2-tum near the mid-region, which enables spatial proximity and interaction
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between the termini. Moreover, the flexibility revealed in the structure, especially for
unrestrained terminal residues, is significant

The importance of this point is

emphasized by mutational studies which propose that specific contacts between these
residues are important in receptor binding and biological function and inactivation
by dimerization (Birr et ah, 1981; Bodenmuller et ah, 1986). In addition, the detailed
molecular dynamics simulations enable us to discern interactions within the
neuropeptide. Particularly, extensive hydrogen bonding is predicted between residues
comprising the /?-tum, as well a between the termini.
In Figure 6, a qualatative model of the dimerized peptide is presented, based
on the model proposed by Bodenmuller et al. (1986). This model, depicts the antiparallel orientation of two HHA molecules apparently stabilized by hydrophobic
contacts between residues near the mid-region /2-tum and hydrophobic carboxyl
residues. Thus, one can imagine that by altering residues at either termini, crucial
hydrogen bonding contacts can be disrupted important to biological function and
dimerization.
In summary, in this study we have presented an analysis of the threedimensional structure of the HHA neuropeptide.

It is shown that the DIKF

representation captures the relative uncertainty of the atomic positions in the peptide
in a useful way for structural comparison, as well as for analysis for the flexible
regions or those ill defined by the data. Further, molecular dynamics simulations
provide insight into the specific interactions present in the peptide, for an
understanding of its biological activity.
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Figure 1. Average variance throughout DIKF calculation.
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Figure 2. Average structure o f the Hydra head activator neuropeptide. The structure
was generated from the average <p and \p angles during the dynamics simulation.
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Figure 3. Plot o f the accessible torsions
during 50 ps of dynamics simulation.

«p and tW sequentially along the backbone
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dynamics simulation for ^i(a), f 3(b), ^ 3(c) and ^u(d).
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Figure 6. Proposed dimer structure o f HHA neuropeptide.
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Table I. Average 0 and
dynamics simulation.

ip angles

Residue

for the hydra head activator during 50 ps of

0 (deg)

IP (deg)
- 107

pGlu1
Pro2

- 61

+ 138

Pro3

- 74

+ 64

Gly4

- 15

+ 59

Gly5

+ 89

- 103

Ser6

- 92

- 24

Lys7

- 107

+ 129

Val8

- 109

+ 114

He9

- 95

+ 123

Leu10

- 112

+ 15

Phe11

- 113
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Table I I . Summary of hydrogen bonding during the dynamics simulation.

CO(pGlu1)....NH(Lys7)*
....NH(Leu10)
______________...,NH(Pheu)
CO(Pro2)....NH(Gly4)
CO(Pro3)....NH(Glys)
CO(Gly4)....NH(Lys7)
______________....NH(Sei*)
CO(Ser*)....NH(Lys7)
....NH(Val8)
CO(Lys7)....NH(Gly4)
CO(Val8)....NH(pGlu1)
_____________ ....NH(Leu10)
CO(Ile9)....NH(Phe11)
CO(Leu10)..-.COOH(Phen)
* Signifies e-amino of lysine side group.
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